Table 5 Immunological and ART status of HIV-positive patients
Variable, n (%) except where specified | HIV+ |
|---|---|
Viral load (copies/mL) (n = 26) | |
Suppressed (< 200) | 17 (65.4%) |
Unsuppressed (> 200) | 9 (34.6%) |
CD4+ count (cells/mm3) (n = 27) | |
Median (IQR) | 271 (355) |
ART status (n = 30) | |
Treated with ART at time of event | 20 (66.7%) |
ART-naïve | 8 (26.7%) |
Defaulted ARTs | 2 (6.7%) |
ART regimen (n = 20) | |
Tenofovir-emtricitibine-efavirenz | 14 (70.0%) |
Abacavir-lamivudine-efavirenz | 1 (5.0%) |
Zidovudine-lamivudine-lopinavir/ritonavir | 4 (20.0%) |
Stavudine-lamivudine-lopinavir/ritonavir | 1 (5.0%) |